SALT LAKE CITY, UT | March 11, 2024 — Pacific BioLabs CEO Michael Spalding and COO Mike Yakes were honored to receive the 25 Year SOT Exhibitor Award presented by […]

Pacific BioLabs (PBL) is pleased to announce the launch of In Vitro Services offering in vitro, cell-based assays supporting the pharmaceutical, biopharma, and medical device industries. The addition of this […]

Pacific BioLabs is pleased to announce that it will continue to receive full accreditation from AAALAC International®, a nonprofit organization promoting the humane treatment of laboratory animals in science through […]

Pacific BioLabs works hard to be The Service Leader in Life Science Testing, and nothing makes us more proud then receiving commendations from our clients. Kyle Schwenker, Chemist at Splintek, Inc. […]

Pacific BioLabs clients are on the cutting edge of developing novel therapeutic approaches to target unmet medical needs.  Nine Continents Medical, Inc., recently acquired by Coloplast a global medical device […]

The International Organization of Standardization (ISO) is an independent organization that develops harmonized standards for use by governmental and non-governmental regulatory agencies. ISO Standard 10993 governs safety testing of medical […]

PBL clients are at the forefront of identifying new targets for drug discovery and development. Ophirex, a San Francisco Bay Area startup company founded by Matthew Lewin, M.D., Ph.D, is […]

Fourier-transformed infrared spectroscopy, also known as FTIR, is a method of analyzing both organic and inorganic materials, and can provide a breakdown of their molecular makeup. Using FTIR, one can analyze […]

As you may be aware from our previous blog post, the European Union published the new Medical Device Regulation (MDR) on May 5th, 2017 and it is expected to be […]

The European Union published the new Medical Device Regulation (MDR) on May 5th, 2017 and it is expected to be enforced starting May 25th, 2020.  This new regulation repeals the […]